Costa Rica is home to more than 60 medical device companies, including Medtronic, Abbott, Boston Scientific, Volcano and Hologic. Due to its highly educated workforce, competitive operating costs and tax…

A study released in January 2015 shows that components etched with NDC’s new proprietary chemical etching process demonstrate superior fatigue resistance at 10 million cycles compared to parts etched with…

It was a pleasure speaking with you and we hope we were able to update you on the latest trends in the Nitinol industry. NDC is a highly innovative and…

At the same time that NDC is expanding its customer portfolio and the diversity of Nitinol medical devices it manufactures, it is also embracing core capabilities in project management. NDC…

To meet the growing demands of customers and to support its existing Nitinol device and component contract manufacturing programs, NDC continues to develop deep bench strength within its technical team…

NDC has developed a new chemical etching process to preferentially remove thermal oxide from the surface of Nitinol based medical device implants. This breakthrough represents another technology NDC can utilize…

NDC recently added nickel ion release and hydrogen testing to its extensive portfolio of testing services specifically for Nitinol implants. NDC has unique expertise running and reporting upon standardized tests…

Reinforcing its strategic focus on endovascular device and component manufacturing, NDC has formed a Crimping Operations Team spanning multiple functions including product development, process engineering, manufacturing and quality. The Crimping…

NDC is in the process of testing a new low-temperature method of applying PTFE and other coatings to Nitinol that will not compromise the alloy’s underlying mechanical properties. PTFE, a…